Decay of the HIV reservoir in patients receiving antiretroviral therapy for extended periods: implications for eradication of virus.
暂无分享,去创建一个
Lawrence Corey | James I Mullins | Susan Moir | Anthony S Fauci | J. Mullins | T. Chun | C. Hallahan | J. Justement | A. Fauci | A. Collier | L. Corey | S. Moir | J. Maenza | Ann C Collier | Tae-Wook Chun | Janine Maenza | J Shawn Justement | Claire W Hallahan | A. Fauci | Ann C. Collier | James I. Mullins
[1] R. Siliciano,et al. Long-term follow-up studies confirm the stability of the latent reservoir for HIV-1 in resting CD4+ T cells , 2003, Nature Medicine.
[2] T. Chun,et al. Early establishment of a pool of latently infected, resting CD4(+) T cells during primary HIV-1 infection. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[3] D. Richman,et al. Recovery of replication-competent HIV despite prolonged suppression of plasma viremia. , 1997, Science.
[4] W. Boscardin,et al. Lack of Decay of HIV-1 in Gut-Associated Lymphoid Tissue Reservoirs in Maximally Suppressed Individuals , 2006, Journal of acquired immune deficiency syndromes.
[5] M A Nowak,et al. Presence of an inducible HIV-1 latent reservoir during highly active antiretroviral therapy. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[6] M. Dybul,et al. Effect of interleukin-2 on the pool of latently infected, resting CD4+ T cells in HIV-1-infected patients receiving highly active anti-retroviral therapy , 1999, Nature Medicine.
[7] T. Chun,et al. Latent reservoirs of HIV: obstacles to the eradication of virus. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[8] Anthony S. Fauci,et al. AIDS: Re-emergence of HIV after stopping therapy , 1999, Nature.
[9] R Brookmeyer,et al. Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy. , 1997, Science.
[10] Matthew C Strain,et al. Effect of treatment, during primary infection, on establishment and clearance of cellular reservoirs of HIV-1. , 2005, The Journal of infectious diseases.
[11] Michael D. George,et al. Viral Suppression and Immune Restoration in the Gastrointestinal Mucosa of Human Immunodeficiency Virus Type 1-Infected Patients Initiating Therapy during Primary or Chronic Infection , 2006, Journal of Virology.
[12] Alan S. Perelson,et al. In a Subset of Subjects on Highly Active Antiretroviral Therapy, Human Immunodeficiency Virus Type 1 RNA in Plasma Decays from 50 to <5 Copies per Milliliter, with a Half-Life of 6 Months , 2003, Journal of Virology.
[13] D. Nickle,et al. HIV-infected individuals receiving effective antiviral therapy for extended periods of time continually replenish their viral reservoir. , 2005, The Journal of clinical investigation.
[14] A. Perelson,et al. Quantifying residual HIV-1 replication in patients receiving combination antiretroviral therapy. , 1999, The New England journal of medicine.